Dealing with Adverse Effects of Anti-Hypertensive Drugs

Presented By: William J. Elliott MD, PhD

Dealing with Adverse Effects of Anti-Hypertensive Drugs

Free CME

Highlights from the University of Chicago Pritzker School of Medicine: Second Annual Comprehensive Review of the Management of Hypertension • Brought To You By The Doctor’s Channel

Estimated Time to Complete Activity

.25 hours per video activity/1.5 hours for entire series

 

Publication Date

December 15, 2011

Faculty for Highlights Program

1. George L. Bakris MD, DMSc (Hon), FAHA, FASN Professor of Medicine Director, Hypertensive Disease Unit The University of Chicago Pritzker School of Medicine Chicago, IL
2. Rajiv Agarwal MD Professor of Medicine Division of Nephrology Indiana University Department of Medicine Indianapolis, IN
3. William C. Cushman MD Professor, Preventive Medicine, Medicine and Physiology University of Tennessee Health Science Center Chief, Preventive Medicine Section, Memphis VA Medical Center Memphis, TN
4. William J. Elliott MD, PhD Professor Preventive Medicine, Internal Medicine and Pharmacology Head, Division of Pharmacology Pacific Northwest University of Health Science Yakima, WA
5. Philip Gorelick MD John S. Garvin Professor & Head Director, Center for Stroke Research Department of Neurology & Rehabilitation University of Illinois College of Medicine at Chicago Chicago, IL
6. Keith C. Norris, MD, FACP Executive VP for Research and Health Affairs Charles Drew University Assistant Dean for Translational Science, UCLA Los Angeles, CA

Who Should Participate/Target Audience

The intended audience for this activity is cardiologists, internists, primary care physicians, and other healthcare professionals who treat and manage hypertension.

Overview of Methods and Participation

This six-video program is designed to improve the diagnosis, management and treatment of hypertension in both the general population and among those who have resistant hypertension. The presentations involve faculty speakers who discuss an individual topic. There are no fees for participating and receiving CME credit for this activity.

Requirements for Claiming Credit

Each of the six videos is eligible for one-quarter (0.25) CME credit. To receive up to one and a half (1.5) CME credits, you must view each of the videos, complete each test associated with the video, achieve a score of 70% or higher on the test, and complete an evaluation form. You will then be able to print out your CME certificate.

Technical Requirements

• A broadband internet connection
• Operating system: Microsoft Windows 98 or later; Mac OS X
• Web browser: Microsoft Internet Explorer 6.0 or later; Mozilla Firefox 1.5 or later; Apple Safari
• Adobe Flash Player 9.0 or later (Available at: http://get.adobe.com/flashplayer/)

Learning Objectives

At the conclusion of the entire initiative, six videos in total, participants should be able to:

1. Implement treatment regimens for hypertension in accordance with current guidelines.
2. Incorporate office-based strategies into practice to improve patient adherence and persistence to antihypertensive medication regimens.
3. Describe the guidelines for employing antihypertensive therapy in the prevention of secondary stroke and the benefits of doing so.
4. Recognize specific populations that are at increased risk of complications due to hypertension.
5. Identify patients who may be at risk for resistant hypertension and modulate and intensify treatment regimens as needed.

Acknowledgement Statements

This continuing education activity is sponsored by The University of Chicago Educational Partner Vindico This continuing education activity is supported by an educational grant from Takeda

Disclosures

Faculty Dr. George Bakris reported consulting for Abbott, Johnson & Johnson, Medtronic, Servier, and Takeda, CVRx, and Walgreens. In addition, he has been involved in investigator-initiated research with Forest Labs, CVRx, Novartis, Medtronic, PepsiCo, and Relapysa. Dr. Rajiv Agarwal reported consulting for Amgen, Abbott, Celgene, Reata, Relypsa, and Rockwell Med. He also reported fees for non-CME services from Abbott and Merck. Dr. William C. Cushman reported consulting for Takeda, Novartis, and Merck. He also reported fees for contracted research from Merck. Dr. William J. Elliott reported research support from Forest Research Institute and royalty fees from Elsevier (Division of Harcourt). He also reported as a consultant for Forest Laboratories, Takeda, and Novartis. He also reported fees for non-CME services from Forest Laboratories, NicOx, Inc. Dr. Phillip B. Gorelick reported consulting for Boehringer Ingelheim and AstraZeneca. He also reported contracted research fees from Lundbeck Inc. He also reported other work including as a member of study committees with Abbott, AstraZeneca, Bayer, Brainsgate, Dendreon, D-Pharm, Roche/Parexel, and Takeda. Dr. Keith C. Norris reported consulting for Amgen and Takeda. He also reported grants from Abbott, Monarch/King, NIH, and Pfizer and being on advisory boards for Abbott, Amgen, and Monarch/King. University of Chicago The planning staff of The University of Chicago has nothing additional to disclose. Vindico The planning staff of Vindico has nothing to disclose. BetterCME

The medical director and production staff of BetterCME have nothing to disclose.

Designation and Accreditation Statements

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this eduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclaimer – Patient Management

This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclaimer – University of Chicago Pritzker School of Medicine and Vindico Medical Education

The material presented at or in any University of Chicago and Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of University of The Chicago and Vindico Medical Education. Neither The University of Chicago and Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the U.S. Food and drug Administration (FDA). All viewers and continuing education participants should verify all information before treating patients or utilizing any product.

Unlabeled and Investigational Usage(s)

The audience is advised that this continuing educational activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Copyright Statement

© All documents accessed from this page are viewed as a resource of The University of Chicago and Vindico Medical Education©, all rights reserved. [2011 The University of Chicago and Vindico Medical Education©.]